Karyopharm to participate at the piper sandler 36th annual healthcare conference

Newton, mass. , nov. 25, 2024 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq: kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the company's senior management team will participate at the piper sandler 36th annual healthcare conference in a fireside chat on tuesday, december 3 at 11:30 a.m.
KPTI Ratings Summary
KPTI Quant Ranking